18+ · Research Use Only · Not for Human Consumption
GHK-Cu topical formulation: from vial to serum.
Dermal research works with formulated vehicles, not raw powder. The concentration math from a 50mg vial, the compounding sequence, and the handling rules that keep the complex intact.
What dermal research formulations look like
Published dermal work on GHK-Cu is built around formulated vehicles: creams, serums and gels carrying the peptide at low concentrations, typically fractions of one percent by weight. The literature covers skin remodeling endpoints, collagen and extracellular-matrix markers, and wound-model outcomes, almost all of it preclinical or small-scale. The consistent theme is that the vehicle matters as much as the peptide, because a topical only works as a research tool if the compound stays stable in it and reaches the tissue layer under study.
Cosmetic-counter products borrow this literature but rarely disclose meaningful concentrations. Research formulation flips that: you start from a known mass of peptide, so the final concentration is exact and reproducible. That is the entire advantage of compounding from a vial.
The compounding math from a 50mg vial
The arithmetic is simple: concentration equals peptide mass divided by final volume. A GHK-Cu 50mg vial compounded into 50ml of base yields 0.1% w/v. Into 25ml it yields 0.2%. Into 10ml, 0.5%. Work backward from the concentration your protocol specifies, then measure the base volume to match.
The standard laboratory sequence runs in two steps. First, reconstitute the lyophilized powder with a small volume of bacteriostatic water, 1 to 2ml, swirled gently until fully dissolved. Never shake: peptides shear. Second, blend that concentrate evenly into the measured base. Working from a liquid concentrate rather than dry powder is what gets you even distribution, since 50mg of powder stirred straight into a viscous cream disperses poorly. The general technique is the same as any peptide prep, covered in the reconstitution walkthrough.
Stability, color and storage
GHK-Cu announces its own condition. The copper complex is distinctly blue, and a properly compounded formulation carries that tint. Loss of color, or a shift toward green or brown, signals the complex is degrading. The compound is also sensitive to strongly acidic vehicles and to oxidizing ingredients, so a plain, mild base is the conservative research choice over a base crowded with actives.
Store the finished formulation refrigerated and compound in small batches rather than converting a whole vial at once, particularly in Philippine ambient heat, which degrades peptides faster than most temperate-climate guidance assumes. The vial itself lists at ₱1,140, or ₱1,030 on a first order, with same-day Metro Manila delivery on verified orders before noon.
Supplied for laboratory research use only. Not for human consumption. Nothing on this page is medical advice.
Formulation questions
What concentration does one 50mg GHK-Cu vial produce?
Dissolved into 50ml of base, 50mg gives 0.1% weight per volume. Into 25ml it gives 0.2%, into 10ml it gives 0.5%. The vial is fixed, so concentration is set entirely by how much base you compound it into.
Why is the solution blue?
The color comes from the copper complex itself. A clear GHK-Cu solution suggests the copper is missing or the complex has broken down. In dermal formulation work the blue tint carries through into the finished serum at visible strength.
Can I formulate directly with bacteriostatic water?
Bacteriostatic water is the standard reconstitution reagent for the vial itself. For a finished topical, the reconstituted concentrate is then blended into a suitable dermal base. The reagent is sold separately at ₱250 for 30ml.
Does topical formulation use a different GHK-Cu product?
No. The same 50mg research vial serves both injectable-style protocols and topical compounding. The two routes are compared in the injectable vs topical post.